{"id":1175,"text":"Investigation was carried out in adult New Zealand white rabbits to study the influence of curcumin pre-treatment on pharmacokinetic disposition of norfloxacin following single oral administration.","label":[[91,99,"Herb name"],[148,159,"Drug"],[170,196,"Frequency"]],"Comments":[]}
{"id":1176,"text":"Sixteen rabbits were divided into two groups of eight each consisting of either sex.","label":[[0,15,"Cohort"]],"Comments":[]}
{"id":1177,"text":"Animals in group-I were administered norfloxacin (100 mg\/kg body weight p.o), while animals in group-II received similar dose of norfloxacin after pre-treatment with curcumin (60 mg\/kg body weight per day, 3 days, p.o).","label":[[37,48,"Drug"],[50,59,"Amount"],[60,71,"Parameter"],[129,140,"Drug"],[166,174,"Herb name"],[176,184,"Amount"],[176,204,"Frequency"],[185,196,"Parameter"],[206,212,"Duration"]],"Comments":[]}
{"id":1178,"text":"Blood samples were drawn from the marginal ear vein into heparin-coated vials at 0 (zero time), 5, 10, 15, 30 min and 1, 2, 4, 6, 12 and 24 h post-treatment.","label":[[57,64,"Parameter"],[81,156,"Duration"]],"Comments":[]}
{"id":1179,"text":"Plasma norfloxacin concentrations were determined by high performance liquid chromatography.","label":[[0,33,"Parameter"],[7,18,"Drug"]],"Comments":[]}
{"id":1180,"text":"The plasma concentration-time profile of norfloxacin was adequately described by a one-compartment open model.","label":[[3,24,"Parameter"],[41,52,"Drug"]],"Comments":[]}
{"id":1181,"text":"The pharmacokinetic data revealed that curcumin-treated animals had significantly (p ≤ 0.05) higher area under the plasma concentration-time curve and area under the first moment of plasma drug concentration-time curve.","label":[[39,47,"Herb name"],[100,146,"Parameter"],[151,218,"Parameter"]],"Comments":[]}
{"id":1182,"text":"Prior treatment of curcumin significantly (p ≤ 0.05) increased elimination half-life and volume of distribution of norfloxacin.","label":[[19,27,"Herb name"],[63,84,"Parameter"],[89,111,"Parameter"],[115,126,"Drug"]],"Comments":[]}
{"id":1183,"text":"Further treatment with curcumin reduced loading and maintenance doses by 26% and 24% respectively.","label":[[23,31,"Herb name"],[73,76,"Amount"],[81,84,"Amount"]],"Comments":[]}
{"id":1184,"text":"Norfloxacin is a member of the fluoroquinolone group of antimicrobial agents.","label":[[0,11,"Drug"],[27,76,"Drug"]],"Comments":[]}
{"id":1185,"text":"It has a wide spectrum of activity, excellent tissue penetration and is rapidly bactericidal at low concentrations.","label":[[46,64,"Parameter"],[100,114,"Parameter"]],"Comments":[]}
{"id":1186,"text":"Norfloxacin has a minimum inhibitory concentration (MIC Turmeric (Curcuma longa) is a medicinal plant extensively used in Ayurveda, Unani and Siddha medicine as a home remedy for various diseases.","label":[[0,11,"Drug"],[18,55,"Parameter"],[56,80,"Herb name"],[187,195,"Pathology"]],"Comments":[]}
{"id":1187,"text":"Curcumin, which is the active component of Curcuma longa, improves the per-os bioavailability of the immunosuppressive agent mylophenolic acid by inhibiting non-specific drug metabolizing enzymes [4].","label":[[0,8,"Herb name"],[43,56,"Herb name"],[71,93,"Parameter"],[97,142,"Drug"],[157,195,"Target"]],"Comments":[]}
{"id":1188,"text":"Similarly, curcumin suppresses drug metabolizing enzymes (CYP3A4) in the liver [23] as well as inducing changes in the drug transporter P-glycoprotein, hence increasing the maximum absorption concentration (C The study was conducted in New Zealand white rabbits weighing 1.65 ± 0.22 kg, divided into two groups with eight rabbits in each group.","label":[[11,19,"Herb name"],[31,65,"Target"],[115,150,"Target"],[169,208,"Parameter"],[271,285,"Amount"]],"Comments":[]}
{"id":1189,"text":"The rabbits were acclimatized for three weeks to laboratory conditions before initiating the experiment.","label":[[30,45,"Duration"]],"Comments":[]}
{"id":1190,"text":"They were housed in individual cages and fed with antibiotic free diet.","label":[[50,60,"Drug"]],"Comments":[]}
{"id":1191,"text":"Feed and water were provided ad libitum.","label":[],"Comments":[]}
{"id":1192,"text":"Feed was withheld for at least 6-8 h before and until 4 h after drug administration.","label":[[18,36,"Duration"],[54,57,"Duration"]],"Comments":[]}
{"id":1193,"text":"Necessary approval from the Institutional Animal Ethics Committee was obtained to carry out the investigation.","label":[],"Comments":[]}
{"id":1194,"text":"Norfloxacin (Aravind Pharma, India) was dissolved in 0.1 N HCl to obtain a 3.33% solution (50 mg of norfloxacin in 1.5 mL 0.1 N HCl).","label":[[0,11,"Drug"],[53,58,"Amount"],[75,80,"Amount"],[91,96,"Amount"],[100,111,"Drug"],[115,121,"Amount"],[122,127,"Amount"],[128,131,"Extraction process"]],"Comments":[]}
{"id":1195,"text":"The required amount of curcumin (Sigma-Aldrich, USA) was dissolved in a mixture of distilled water and Tween-20 at a 2 : 1 ratio restricting the total volume to 4-5 mL.","label":[[23,31,"Herb name"],[161,167,"Amount"]],"Comments":[]}
{"id":1196,"text":"Group-I rabbits (control) received norfloxacin at the rate of 100 mg\/kg body weight as a single oral dose.","label":[[35,46,"Drug"],[62,71,"Amount"],[72,83,"Parameter"],[89,105,"Frequency"]],"Comments":[]}
{"id":1197,"text":"The rabbits in group-II were administered a similar dose of norfloxacin after pre-treatment with curcumin (60 mg\/kg body weight; p.o) for three days at an interval of 24 h. Blood samples (1.0-1.5 mL) were aseptically drawn from the marginal ear vein into heparin-coated tubes (Hi-Media, India) immediately before (0) at 5, 10, 15 and 30 min, and 1, 2, 4, 6, 8, 12 and 24 h after the administration of norfloxacin.","label":[[60,71,"Drug"],[97,105,"Herb name"],[107,115,"Amount"],[116,127,"Parameter"],[134,148,"Duration"],[167,171,"Duration"],[188,198,"Amount"],[255,262,"Parameter"],[306,340,"Duration"],[346,378,"Duration"],[401,412,"Drug"]],"Comments":[]}
{"id":1198,"text":"Plasma samples were obtained by centrifugation of each blood sample (1,250 ×g, 10 min) and were stored at -20℃ (for not more than 24 h) until being assayed.","label":[[69,77,"Amount"],[79,85,"Duration"],[106,109,"Amount"],[109,110,"Parameter"],[130,134,"Duration"]],"Comments":[]}
{"id":1199,"text":"Plasma norfloxacin concentrations were determined using high performance liquid chromatography (HPLC; Shimadzu, Japan).","label":[[0,33,"Parameter"],[7,18,"Drug"]],"Comments":[]}
{"id":1200,"text":"Dilutions of norfloxacin (E. Merck, India) ranging from 0.01-4 mg\/mL were carried out with the mobile phase to obtain a standard curve.","label":[[13,24,"Drug"],[56,68,"Amount"]],"Comments":[]}
{"id":1201,"text":"The HPLC system consisted of double pump (LC-20AT), rheodyne manual injector with 20 µL loop, dual wavelength ultraviolet detector (SPD-20A) and LC Solution software for data analysis.","label":[],"Comments":[]}
{"id":1202,"text":"Chromatography was carried out using a reverse phase C The plasma concentration-time profile of norfloxacin of each experimental animal was used to determine its pharmacokinetics.","label":[[59,79,"Parameter"],[96,107,"Drug"]],"Comments":[]}
{"id":1203,"text":"The pharmacokinetic data of norfloxacin was analyzed using the 'method of least square' and 'method of residual yields' [8].","label":[[28,39,"Drug"]],"Comments":[]}
{"id":1204,"text":"The compartmental analysis of the data was undertaken using the mono-exponential equation: C where, C The total AUC and area under the first moment of plasma drug concentration-time curve (AUMC) were calculated as described previously [18].","label":[[102,115,"Parameter"],[120,194,"Parameter"]],"Comments":[]}
{"id":1205,"text":"The volume of distribution (V The loading and maintenance dosage schedules were selected to maintain a MIC of 0.1, 0.5 and 1.0 µg\/mL in plasma [12].","label":[[0,29,"Parameter"],[103,106,"Parameter"],[110,113,"Amount"],[115,118,"Amount"],[123,132,"Amount"]],"Comments":[]}
{"id":1206,"text":"The difference between the means of the two treatments was determined by student's t-test [21] and the data were analyzed using GraphPad Instant software (GraphPad Software, USA).","label":[],"Comments":[]}
{"id":1207,"text":"The mean plasma concentration of norfloxacin was significantly (p ≤ 0.05) higher in curcumin pre-treated rabbits, although such effect was not observed during the entire period of absorption phase (Table 1, Fig.","label":[[0,44,"Parameter"],[33,44,"Drug"],[84,92,"Herb name"]],"Comments":[]}
{"id":1208,"text":"1).","label":[],"Comments":[]}
{"id":1209,"text":"The plasma concentration of norfloxacin persisted up to 24 h in curcumin-treated rabbits, while it was detected up to 12 h in the untreated control group (Table 1).","label":[[0,39,"Parameter"],[28,39,"Drug"],[56,60,"Duration"],[64,72,"Herb name"],[118,122,"Duration"]],"Comments":[]}
{"id":1210,"text":"The absorption rate constant and absorption half-life revealed a significant (p ≤ 0.05) change (Table 2).","label":[[0,28,"Parameter"],[33,53,"Parameter"]],"Comments":[]}
{"id":1211,"text":"Prior administration of curcumin modified the kinetic profile of norfloxacin as evidenced by the higher AUC, AUMC and mean resident time.","label":[[24,32,"Herb name"],[65,76,"Drug"],[104,107,"Parameter"],[108,113,"Parameter"],[118,136,"Parameter"]],"Comments":[]}
{"id":1212,"text":"Prior administration of curcumin significantly (p ≤ 0.05) reduced the elimination rate constant (β) and consequently increased the half-life of norfloxacin.","label":[[24,32,"Herb name"],[66,99,"Parameter"],[127,155,"Parameter"],[144,155,"Drug"]],"Comments":[]}
{"id":1213,"text":"Similarly, there was a significant increase in V Norfloxacin has antimicrobial activity against a wide range of bacteria and is being effectively used to treat respiratory, urinary and gastro-intestinal tract infections in man and animals.","label":[[47,48,"Parameter"],[49,60,"Drug"],[160,219,"Pathology"]],"Comments":[]}
{"id":1214,"text":"Pharmacokinetic studies on norfloxacin in rabbits are limited [14,19].","label":[[27,38,"Drug"]],"Comments":[]}
{"id":1215,"text":"The absorption of norfloxacin from gastrointestinal tract is limited [5,9].","label":[[0,29,"Parameter"],[18,29,"Drug"]],"Comments":[]}
{"id":1216,"text":"Curcumin, a flavonoid isolated from Curcuma longa, improves the therapeutic concentrations of co-administered drugs [4,24].","label":[[0,49,"Herb name"],[60,90,"Parameter"]],"Comments":[]}
{"id":1217,"text":"With this background, the present study was undertaken to examine the influence of curcumin on the disposition profile of norfloxacin in rabbits after oral administration.","label":[[83,91,"Herb name"],[122,133,"Drug"]],"Comments":[]}
{"id":1218,"text":"The disposition of norfloxacin after a single oral dose (100 mg\/kg body weight) was examined in rabbits with or without prior exposure to curcumin.","label":[[19,30,"Drug"],[37,55,"Frequency"],[57,66,"Amount"],[67,78,"Parameter"],[138,146,"Herb name"]],"Comments":[]}
{"id":1219,"text":"A similar dose (per os) has been used to describe plasma and tissue concentration of norfloxacin in rabbits [19].","label":[[50,96,"Parameter"],[85,96,"Drug"]],"Comments":[]}
{"id":1220,"text":"The observed plasma concentration-time profile of norfloxacin was best described by the one compartment open model.","label":[[13,33,"Parameter"],[50,61,"Drug"]],"Comments":[]}
{"id":1221,"text":"The plasma levels of norfloxacin (group-I) at different time intervals were comparable to previous studies in rabbits receiving a similar dose [19], however, the plasma half-life was relatively short [14].","label":[[0,32,"Parameter"],[21,32,"Drug"],[158,178,"Parameter"]],"Comments":[]}
{"id":1222,"text":"The increased plasma levels of norfloxacin observed in the present study (group-II) may be due to the by-pass of glucuronidation process in the intestine since curcumin was reported to suppress UDP-glucuronyltransferase levels in intestine and hepatic tissue [4].","label":[[14,42,"Parameter"],[31,42,"Drug"],[113,136,"Parameter"],[160,168,"Herb name"],[194,219,"Target"],[194,258,"Parameter"]],"Comments":[]}
{"id":1223,"text":"Furthermore, the ability of curcumin to suppress CYP3A4 drug metabolizing enzymes [23] might have delayed the excretion of norfloxacin.","label":[[28,36,"Herb name"],[49,55,"Parameter"],[49,81,"Target"],[106,134,"Parameter"],[123,134,"Drug"]],"Comments":[]}
{"id":1224,"text":"It is more likely that the increased absorption observed in the present study may have been due to the ability of curcumin to influence drug transporter protein (P-gp) in the intestine, as occurs with celiprolol [24].","label":[[37,47,"Parameter"],[114,122,"Herb name"],[136,167,"Parameter"],[201,211,"Drug"]],"Comments":[]}
{"id":1225,"text":"Similarly, curcumin and gingerol (from ginger) were observed to inhibit P-gp mediated  Norfloxacin undergoes extensive metabolism in the liver involving both Phase-I and Phase-II [1].","label":[[11,19,"Herb name"],[24,46,"Herb name"],[72,76,"Parameter"],[72,98,"Target"],[87,98,"Drug"]],"Comments":[]}
{"id":1226,"text":"The significantly higher values of AUC, AUMC and mean residence time (MRT) observed in the present study might be attributable to the enhanced systemic availability of norfloxacin consequent to inhibition of enzymes mostly concerned with the hepatic metabolism of norfloxacin.","label":[[35,38,"Parameter"],[40,44,"Parameter"],[49,74,"Parameter"],[143,179,"Parameter"],[168,179,"Drug"],[208,275,"Target"],[264,275,"Drug"]],"Comments":[]}
{"id":1227,"text":"Furthermore, in contrast to the fact that curcumin can induce hepatic glucuronyltransferase, its suppression at a higher dose cannot be ruled out.","label":[[42,50,"Herb name"],[62,91,"Target"]],"Comments":[]}
{"id":1228,"text":"It is noteworthy that curcumin is itself metabolized through hepatocytes as glucuronides of tetrahydrocurcumin [13] and, therefore, the metabolism of norfloxacin may be delayed due to competition between two substrates.","label":[[22,30,"Herb name"],[61,110,"Parameter"],[132,161,"Parameter"],[150,161,"Drug"]],"Comments":[]}
{"id":1229,"text":"The higher plasma elimination half life (t From a practical point of view, a dosage regimen of 80 and 77 mg\/kg of norfloxacin alone or 60 and 55 mg\/kg of norfloxacin after curcumin pre-treatment as the loading and maintenance dose, respectively, at a 12 h interval adequately maintains optimal therapeutic concentration of 0.5 µg\/mL plasma against resistant pathogens infecting rabbits.","label":[[11,39,"Parameter"],[95,97,"Amount"],[102,110,"Amount"],[114,125,"Drug"],[135,137,"Amount"],[142,150,"Amount"],[154,165,"Drug"],[172,180,"Herb name"],[251,264,"Duration"],[294,319,"Parameter"],[323,339,"Amount"]],"Comments":[]}
{"id":1230,"text":"The reduction in the loading and maintenance doses indicates that prior administration of curcumin is of economic significance as well as being capable of reducing side effects, as a lesser amount of drug would be required.","label":[[90,98,"Herb name"],[164,176,"Pathology"]],"Comments":[]}
{"id":1231,"text":"The bioenhancer nature of curcumin is comparable to piperine [20], an alkaloid obtained from Piper longum.","label":[[26,34,"Herb name"],[52,105,"Herb name"]],"Comments":[]}
{"id":1232,"text":"Thus, bioenhancer properties of curcumin can be clinically exploited after appropriate dose titration studies.","label":[[32,40,"Herb name"]],"Comments":[]}
{"id":1233,"text":"The authors are thankful to the Dean of the Veterinary College, Karnataka Animal, Veterinary and Fishery Sciences University, Bidar, for providing the necessary facilities to carry out the investigation.","label":[],"Comments":[]}
{"id":1234,"text":"Semilogarithmic plot of plasma concentration-time profile of norfloxacin in control (Group-I) and curcumin treated (Group-II) rabbits following single oral dose administration.","label":[[24,44,"Parameter"],[61,72,"Drug"],[98,106,"Herb name"],[144,160,"Frequency"]],"Comments":[]}
{"id":1235,"text":"Comparison of mean plasma levels of norfloxacin (mg\/mL) at different time intervals following oral administration in control (Group-I) and curcumin treated (Group-II) rabbits Comparative pharmacokinetics of orally administered norfloxacin (100 mg\/kg body weight) in control (Group-I) and curcumin treated (Group-II) rabbits Dosage regimen of norfloxacin, calculated on the basis of pharmacokinetics values of obtained following oral administration of curcumin treated (Group-II) and control (Group-I) rabbits at various dosage intervals for microorganisms of different susceptibilities","label":[[14,55,"Parameter"],[36,47,"Drug"],[139,147,"Herb name"],[227,238,"Drug"],[240,249,"Amount"],[250,261,"Parameter"],[288,296,"Herb name"],[342,353,"Drug"],[451,459,"Herb name"]],"Comments":[]}
